Related Experiment Video
Updated: Oct 20, 2025

05:15
Production of Humanized Mouse via Thymic Renal Capsule Grafting, CD34+ Cells Injection, and Cytokine Delivery
Published on: September 27, 2021
1.4K
The Th1 cell regulatory circuitry is largely conserved between human and mouse
Stephen Henderson1, Venu Pullabhatla2, Arnulf Hertweck3
1Bill Lyons Informatics Centre, UCL Cancer Institute and CRUK UCL Centre, University College London, London, UK.
Life Science Alliance
|September 17, 2021
Summary
Most genes regulated by T-bet, a key transcription factor for T helper type I (Th1) immunity, are conserved between mice and humans. This cross-species conservation impacts understanding of immune responses and disease.
Area of Science:
- Immunology
- Genomics
- Molecular Biology
Background:
- Lineage-determining transcription factors often have conserved gene targets across species.
- Immune-specific transcription factors, like T-bet (Tbx21), regulate T helper type I (Th1) immunity, crucial for intracellular pathogen defense and inflammatory diseases.
- Evolutionary pressures from infectious diseases may drive divergence in immune gene regulation.
Purpose of the Study:
- To compare T-bet genomic targets in mouse and human CD4+ T cells.
- To correlate T-bet binding patterns with species-specific gene expression.
- To understand cross-species conservation and divergence in Th1 immune gene regulation.
Main Methods:
- Genome-wide comparison of T-bet binding sites in mouse and human CD4+ T cells.
- Analysis of T-bet binding patterns and associated gene expression.
- Identification of conserved and species-specific T-bet targets.
Main Results:
- The majority of T-bet target genes are conserved between mouse and human.
- Conservation occurs through preserved binding sites or alternative sites linked to transposons.
- Species-specific T-bet binding correlates with distinct transcription factor motifs and gene expression.
Conclusions:
- T-bet-mediated Th1 gene regulation shows significant cross-species conservation.
- Understanding conserved and divergent T-bet targets is vital for translating preclinical findings to human trials.
- This study provides a foundation for improved therapeutic strategies in inflammatory diseases, infectious diseases, and cancer.

